174 related articles for article (PubMed ID: 35333997)
1. Uremic toxin indoxyl sulfate induces dysfunction of vascular smooth muscle cells via integrin-β1/ERK signaling pathway.
Yu H; Zhou C; Hu D; Li C; Wang Q; Xue W; Peng A
Clin Exp Nephrol; 2022 Jul; 26(7):640-648. PubMed ID: 35333997
[TBL] [Abstract][Full Text] [Related]
2. The role of AMP-activated protein kinase α1-mediated endoplasmic reticulum stress in alleviating the toxic effect of uremic toxin indoxyl sulfate on vascular endothelial cells by Klotho.
Chen C; Wu L; Xie C; Zhao X; Mao H; Xing C
J Appl Toxicol; 2021 Sep; 41(9):1446-1455. PubMed ID: 33458837
[TBL] [Abstract][Full Text] [Related]
3. Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells.
Shimizu H; Hirose Y; Goto S; Nishijima F; Zrelli H; Zghonda N; Niwa T; Miyazaki H
Life Sci; 2012 Sep; 91(5-6):172-7. PubMed ID: 22781707
[TBL] [Abstract][Full Text] [Related]
4. Indoxyl sulfate promotes the atherosclerosis through up-regulating the miR-34a expression in endothelial cells and vascular smooth muscle cells in vitro.
Li X; Lu Z; Zhou F; Jin W; Yang Y; Chen S; Xie Z; Zhao Y
Vascul Pharmacol; 2020 Aug; 131():106763. PubMed ID: 32593718
[TBL] [Abstract][Full Text] [Related]
5. Impact of Uremic Toxins on Endothelial Dysfunction in Chronic Kidney Disease: A Systematic Review.
Harlacher E; Wollenhaupt J; Baaten CCFMJ; Noels H
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008960
[TBL] [Abstract][Full Text] [Related]
6. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
[TBL] [Abstract][Full Text] [Related]
7. Indoxyl sulfate-induced calcification of vascular smooth muscle cells via the PI3K/Akt/NF-κB signaling pathway.
He X; Jiang H; Gao F; Liang S; Wei M; Chen L
Microsc Res Tech; 2019 Dec; 82(12):2000-2006. PubMed ID: 31448474
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia Promotes Human Umbilical Vein Smooth Muscle Cell Phenotypic Switching via the ERK 1/2/c-fos/NF-κB Signaling Pathway.
Zhang W; Guo Z; Li L; Shi Z; Zhu T
Ann Vasc Surg; 2022 Aug; 84():371-380. PubMed ID: 35405275
[TBL] [Abstract][Full Text] [Related]
9. Indoxyl sulfate counteracts endothelial effects of erythropoietin through suppression of Akt phosphorylation.
Adelibieke Y; Shimizu H; Saito S; Mironova R; Niwa T
Circ J; 2013; 77(5):1326-36. PubMed ID: 23337206
[TBL] [Abstract][Full Text] [Related]
10. Histopathological and proteomic analyses identify integrin-β1 as a potential mediator of phlebosclerosis in uremic patients.
Zhou C; Li C; Wang Q; Wu M; Mohan C; Hu D; Peng A
Clin Exp Nephrol; 2019 Sep; 23(9):1100-1108. PubMed ID: 31214872
[TBL] [Abstract][Full Text] [Related]
11. Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance.
Daneshamouz S; Eduok U; Abdelrasoul A; Shoker A
NanoImpact; 2021 Jan; 21():100299. PubMed ID: 35559786
[TBL] [Abstract][Full Text] [Related]
12. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.
Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
14. [Research progress of the uremic toxin indoxyl sulfate in cardiovascular complication of end-stage renal diseases].
Guo CC; Xia WW; Zhang AH
Sheng Li Xue Bao; 2018 Dec; 70(6):657-662. PubMed ID: 30560276
[TBL] [Abstract][Full Text] [Related]
15. Indoxyl sulfate enhances IL-1β-induced E-selectin expression in endothelial cells in acute kidney injury by the ROS/MAPKs/NFκB/AP-1 pathway.
Shen WC; Liang CJ; Huang TM; Liu CW; Wang SH; Young GH; Tsai JS; Tseng YC; Peng YS; Wu VC; Chen YL
Arch Toxicol; 2016 Nov; 90(11):2779-2792. PubMed ID: 26659566
[TBL] [Abstract][Full Text] [Related]
16. Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.
Guo J; Lu L; Hua Y; Huang K; Wang I; Huang L; Fu Q; Chen A; Chan P; Fan H; Liu ZM; Wang BH
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H1-H13. PubMed ID: 28411233
[TBL] [Abstract][Full Text] [Related]
17. Indoxyl Sulfate-Induced Extracellular Vesicles Released from Endothelial Cells Stimulate Vascular Smooth Muscle Cell Proliferation by Inducing Transforming Growth Factor-Beta Production.
Ryu JH; Jeon EY; Kim SJ
J Vasc Res; 2019; 56(3):129-138. PubMed ID: 31085925
[TBL] [Abstract][Full Text] [Related]
18. Uremic endothelial-derived extracellular vesicles: Mechanisms of formation and their role in cell adhesion, cell migration, inflammation, and oxidative stress.
Favretto G; da Cunha RS; Flores Santos A; Leitolis A; Schiefer EM; Gregório PC; Franco CRC; Massy Z; Dalboni MA; Stinghen AEM
Toxicol Lett; 2021 Sep; 347():12-22. PubMed ID: 33945863
[TBL] [Abstract][Full Text] [Related]
19. Indoxyl Sulfate, a Uremic Endotheliotoxin.
Lano G; Burtey S; Sallée M
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260489
[TBL] [Abstract][Full Text] [Related]
20. Effects of integrin α5β1 on the proliferation and migration of human aortic vascular smooth muscle cells.
Song Y; Qin X; Wang H; Miao R; Zhang Y; Miao C; Wang Z
Mol Med Rep; 2016 Feb; 13(2):1147-55. PubMed ID: 26648324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
